new glp-1 drug retatrutide Unapproved weight loss causes extreme side effects New GLP-3 drug significantly slashes

No association between a thyrotropin receptor gene polymorphism and Graves' disease in the female population

"Childhood Functional GI Disorders: Neurogastroenterology Approaches." Neurogastroenterol Motil , 2016

The treatment significantly improved stool frequency and overall quality of life, compared with a placebo treatment ( Although senna is generally considered safe, it can lead to adverse effects when used for long periods at high dosages

Journal of Strength and Conditioning Research

NAD+ precursor supplements (NR or NMN) and direct glutathione supplementation both increase their respective molecules, with clinical trials showing 40-90% increases in blood levels at appropriate doses